Lumicell says it received approval from the FDA for a pilot feasibility study of its intraoperative breast cancer imaging system.
Lumicell Diagnostics said it won an investigational device exemption from the FDA for a pilot feasibility trial of its imaging system for breast cancer surgeries.
The study is slated to be conducted at the Mass. General Hospital in Boston, the company said.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1el9qSl
Cap comentari:
Publica un comentari a l'entrada